CARLOS GARCIA PRIETO: Open Payments
NPI 1689728800 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,337 in 58 payments from 11 companies in 2025. Trend: 2023 $1,444 · 2024 $1,233 · 2025 $1,337
Food & beverage: $1,337
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $205 |
| Alkermes, Inc. | 6 | $158 |
| Axsome Therapeutics, Inc. | 8 | $138 |
| Lundbeck LLC | 4 | $115 |
| ABBVIE INC. | 4 | $104 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| PFIZER INC. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
Products named: TRINTELLIX, CAPLYTA, REXULTI, ARISTADA, Auvelity, FANAPT, NURTEC ODT, COBENFY.
Industry payments across FL — which companies pay providers there.
